Catalysts for $PFE
643 tracked
May 9, 2023
approval
ELELYSO (TALIGLUCERASE ALFA) — FDA approval
taliglucerase alfa
→
Jan 31, 2023
approval
SYNAREL (NAFARELIN ACETATE) — FDA approval
nafarelin acetate
→
Dec 19, 2022
approval
ALDACTONE (SPIRONOLACTONE) — FDA approval
ALDACTONE
→
Dec 19, 2022
approval
ALDACTAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Aug 30, 2022
approval
ELELYSO (TALIGLUCERASE ALFA) — FDA approval
taliglucerase alfa
→
Jul 29, 2022
approval
ABRILADA (ADALIMUMAB-AFZB) — FDA approval
ABRILADA
→
Jul 27, 2022
approval
ESTRING (ESTRADIOL) — FDA approval
estradiol ER
→
May 20, 2022
approval
CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval
CLEOCIN
→
May 20, 2022
approval
CLEOCIN HYDROCHLORIDE (CLINDAMYCIN HYDROCHLORIDE) — FDA approval
clindamycin hydrochloride
→
May 20, 2022
approval
CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval
CLEOCIN
→
Apr 27, 2022
approval
IDARUBICIN HYDROCHLORIDE — FDA approval
IDARUBICIN HYDROCHLORIDE
→
Apr 22, 2022
approval
SYNAREL (NAFARELIN ACETATE) — FDA approval
nafarelin acetate
→
Apr 11, 2022
approval
NURTEC ODT (RIMEGEPANT SULFATE) — FDA approval
rimegepant sulfate ODT
→
Mar 31, 2022
approval
NURTEC ODT (RIMEGEPANT SULFATE) — FDA approval
rimegepant sulfate ODT
→
Dec 14, 2021
approval
XELJANZ (TOFACITINIB CITRATE) — FDA approval
tofacitinib citrate ER
→
Dec 14, 2021
approval
XELJANZ XR (TOFACITINIB CITRATE) — FDA approval
tofacitinib citrate ER
→
Dec 8, 2021
approval
NURTEC ODT (RIMEGEPANT SULFATE) — FDA approval
rimegepant sulfate ODT
→
Dec 4, 2021
approval
CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) — FDA approval
CLEOCIN
→
Dec 4, 2021
approval
CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER (CLINDAMYCIN PHOSPHATE) — FDA approval
CLEOCIN
→
Dec 2, 2021
approval
XELJANZ (TOFACITINIB CITRATE) — FDA approval
tofacitinib citrate ER
→
Dec 2, 2021
approval
XELJANZ XR (TOFACITINIB CITRATE) — FDA approval
tofacitinib citrate ER
→
Aug 2, 2021
approval
METHOTREXATE SODIUM PRESERVATIVE FREE (METHOTREXATE SODIUM) — FDA approval
PFIZER INC
→
Aug 2, 2021
approval
METHOTREXATE SODIUM PRESERVATIVE FREE (METHOTREXATE SODIUM) — FDA approval
PFIZER INC
→
May 27, 2021
approval
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
May 27, 2021
approval
NURTEC ODT (RIMEGEPANT SULFATE) — FDA approval
rimegepant sulfate ODT
→
Mar 3, 2021
approval
LORBRENA (LORLATINIB) — FDA approval
lorlatinib
→
Feb 26, 2021
approval
LORBRENA (LORLATINIB) — FDA approval
lorlatinib
→
Feb 19, 2021
approval
ALDACTAZIDE (HYDROCHLOROTHIAZIDE) — FDA approval
ALDACTAZIDE
→
Feb 11, 2021
approval
DEPO-MEDROL (METHYLPREDNISOLONE ACETATE) — FDA approval
METHYLPREDNISOLONE ACETATE
→
Feb 10, 2021
approval
IDARUBICIN HYDROCHLORIDE — FDA approval
IDARUBICIN HYDROCHLORIDE
→